OS Therapies Statistics

Total Valuation

OS Therapies has a market cap or net worth of $70.25 million. The enterprise value is $67.77 million.

Market Cap	70.25M
Enterprise Value	67.77M

Important Dates

The next estimated earnings date is Friday, November 14, 2025, before market open.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

OS Therapies has 31.65 million shares outstanding. The number of shares has increased by 286.83% in one year.

Current Share Class	31.65M
Shares Outstanding	31.65M
Shares Change (YoY)	+286.83%
Shares Change (QoQ)	+18.19%
Owned by Insiders (%)	27.32%
Owned by Institutions (%)	0.73%
Float	20.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	13.50
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.03

Current Ratio	1.03
Quick Ratio	0.81
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-34.22

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-163.50%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-222.43%
Revenue Per Employee	n/a
Profits Per Employee	-$3.25M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.47% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-35.47%
50-Day Moving Average	1.95
200-Day Moving Average	2.15
Relative Strength Index (RSI)	53.29
Average Volume (20 Days)	640,219

Short Selling Information

The latest short interest is 545,038, so 1.72% of the outstanding shares have been sold short.

Short Interest	545,038
Short Previous Month	348,363
Short % of Shares Out	1.72%
Short % of Float	2.70%
Short Ratio (days to cover)	0.80

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-15.24M
Pretax Income	n/a
Net Income	-16.25M
EBITDA	-15.13M
EBIT	-15.24M
Earnings Per Share (EPS)	-$0.74

Full Income Statement

Balance Sheet

The company has $2.80 million in cash and n/a in debt, giving a net cash position of $2.80 million or $0.09 per share.

Cash & Cash Equivalents	2.80M
Total Debt	n/a
Net Cash	2.80M
Net Cash Per Share	$0.09
Equity (Book Value)	6.75M
Book Value Per Share	0.17
Working Capital	95,942

Full Balance Sheet

Cash Flow

Operating Cash Flow	-11.56M
Capital Expenditures	n/a
Free Cash Flow	-11.56M
FCF Per Share	-$0.37

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OS Therapies does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-286.83%
Shareholder Yield	-286.83%
Earnings Yield	-23.03%
FCF Yield	-16.38%

Analyst Forecast

The average price target for OS Therapies is $18.00, which is 710.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.00
Price Target Difference	710.81%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2